Aldeyra Therapeutics Reports Third Quarter and Year to Date 2015 Financial and Operating Results

Go back to Aldeyra Therapeutics Reports Third Quarter and Year to Date 2015 Financial and Operating Results

Aldeyra Therapeutics (ALDX) Misses Q3 EPS by 5c

November 12, 2015 7:33 AM EST

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q3 EPS of ($0.35), $0.05 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More